Sep 13, 2016 11:00 am UTC| Business
Preclinical study of RGX-111 for the treatment of Mucopolysaccharidosis Type I (MPS I) demonstrates disease correction from a single administration of NAV AAV9 in a canine model; expected to help establish minimum...
Heat Biologics to Present at Two Upcoming Investor Conferences
Sep 13, 2016 11:00 am UTC| Business
DURHAM, N.C., Sept. 13, 2016 -- Heat Biologics, Inc. (“Heat”) (Nasdaq:HTBX), an immuno-oncology company developing novel therapies that activate a patient’s immune system against cancer, announced that the company is...
Actinium Pharmaceuticals Presenting at Rodman & Renshaw 18th Annual Global Investment Conference
Sep 13, 2016 11:00 am UTC| Business
Company to Present on Tuesday, September 13, 2016 at 10:25 AM ETPresentation can be viewed via webcast NEW YORK, Sept. 13, 2016 -- Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) ("Actinium" or "the Company"), a...
Sep 13, 2016 11:00 am UTC| Business
VANCOUVER, British Columbia and DOYLESTOWN, Pa., Sept. 13, 2016 -- Arbutus Biopharma Corporation (Nasdaq:ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, today announced that Dr. Michael...
Sep 13, 2016 10:45 am UTC| Business
NEW YORK, Sept. 13, 2016 -- FXCM Inc. (NYSE:FXCM) today announced that it is transferring its stock exchange listing to The NASDAQ Global Market. The last day of trading on The New York Stock Exchange, will be Friday...
Sep 13, 2016 10:37 am UTC| Business
Dublin, Sept. 13, 2016 -- Research and Markets has announced the addition of the "Last Mile: E-Commerce And the Future of the Trucking Industry- U.S. Markets, Technological Disruptions And Innovations,...
Molecular Diagnostics Market To Reach $17.9 Billion By 2024: Grand View Research, Inc.
Sep 13, 2016 10:30 am UTC| Business
San Francisco, Sept. 13, 2016 -- Global molecular diagnostics market is expected to reach over USD 17.9 billion by 2024, based on a new report by Grand View Research, Inc. Increasing prevalence of infectious diseases...